Multiple sclerosis market to generate sales of $29.8 billion by 2030, forecasts GlobalData
Several late-stage pipeline products have the potential to address some of these unmet needs
Several late-stage pipeline products have the potential to address some of these unmet needs
Prometheus Biosciences’ comprehensive data set enables target discovery and precision medicine approach in inflammation and immunology
Various healthcare companies are already implementing high-tech solutions into existing healthcare systems.
Proposed combination enhances Pfizer’s position as a leading company in oncology
The forecast across the seven years between 2022 and 2028 saw an average decline of 7%, resulting in a $10 billion drop in the total forecast sales between 2021 and 2028
Diagnostic imaging will become an increasingly vital process in healthcare
The use of procalcitonin testing for sepsis management is highest in the US
Singapore presents great opportunities for the adoption of technology in healthcare and is open for investments
Fund VI will focus on investments in industrials and healthcare businesses with proven technologies and solutions positioned to deliver high performance and value-add to their customers
Subscribe To Our Newsletter & Stay Updated